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Eosinophilic granulomatosis with polyangiitis (EGPA,  Churg-Strauss syndrome) is a rare systemic 
vasculitis and is diﬃcult to diagnose.  EGPA has a number of symptoms including peripheral dysesthe-
sia caused by mononeuropathy multiplex,  which is similar to radiculopathy due to lumbar disc hernia 
or lumbar spinal stenosis.  Therefore,  EGPA patients with mononeuropathy multiplex often visit 
orthopedic clinics,  but orthopedic doctors and spine neurosurgeons have limited experience in diagnos-
ing EGPA because of its rarity.  We report a consecutive series of patients who were initially diag-
nosed as having lumbar disc hernia or lumbar spinal stenosis by at least 2 medical institutions from 
March 2006 to April 2013 but whose ﬁnal diagnosis was EGPA.  All patients had past histories of 
asthma or eosinophilic pneumonia,  and four out of ﬁve had peripheral edema.  Laboratory data 
showed abnormally increased eosinophil counts,  and nerve conduction studies of all patients revealed 
axonal damage patterns.  All patients recovered from paralysis to a functional level after high-dose 
steroid treatment.  We shortened the duration of diagnosis from 49 days to one day by adopting a 
diagnostic algorithm after experiencing the ﬁrst case.
Key words: eosinophilic granulomatosis with polyangiitis,  mononeuropathy multiplex,  lumbar disc hernia,  
lumbar spinal stenosis,  nerve conduction study
E osinophilic granulomatosis with polyangiitis (Churg-Strauss,  EGPA) is a systemic necrotiz-
ing vasculitis that invades small to medium vessels [1,  
2],  and it is diﬃcult to diagnose because of its rarity 
[3].  The primary symptoms often arise from asthma 
or eosinophilic pneumonia,  and mononeuropathy mul-
tiplex occurs in 50-78  of all EGPA patients [1,  4,  
5].  Mononeuropathy multiplex in the lower extremi-
ties causes muscle weakness and dysesthesia,  and 
these symptoms are similar to radiculopathy due to 
lumbar disc hernia (LDH) or lumbar spinal stenosis 
(LSS) [6].  Therefore,  some patients visit orthopedic 
clinics [7].  However,  orthopedic doctors and spine 
neurosurgeons as well as physicians have few opportu-
nities to diagnose or treat EGPA patients because of 
its rarity.  Because mononeuropathy multiplex of 
EGPA requires early diagnosis and high-dose steroid 
treatment [4,  5],  delays in diagnosing EGPA should 
be avoided [7].
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　 From March 2006 to April 2013,  we experienced 
consecutive series of 5 patients who were introduced 
to our department by other clinics as LDH or LSS 
patients but who fulﬁlled the American College of 
Rheumatology (ACR) diagnosis criteria for EGPA 
(Table 1) [8].  All patients had visited more than 2 
institutions prior to coming to our department.  Four 
were initially diagnosed as having LDH and one as 
having LSS.  Lumbar lesion was ruled out with mag-
netic resonance imaging (MRI) or physical examination 
by at least 2 spine surgeons.  Similarly,  diabetic 
radiculopathy was ruled out (fasting blood glucose was 
found to be less than 110mg/dl before breakfast two 
or more times).
　 Here,  we report a case series of EGPA initially 
diagnosed as LDH or LSS by at least two medical 
institutions.  To the best of our knowledge,  no previ-
ous report detailing the clinical prognosis of periph-
eral neuropathy in the lower extremities associated 
with EGPA has been documented.
Case Reports
　 Case 1. A 58-year-old female patient suﬀered 
from pain in both legs for 3 months and diarrhea with 
abdominal pain for 1 month.  She was introduced to our 
institute as a having radiculopathy of LSS.  She had 
been diagnosed with asthma 9 years previously.  In a 
physical examination,  she showed pitting edema and 
muscle weakness in both lower limbs (Table 2) and 
dysesthesia in both feet.  She did not have low back 
pain.  Straight leg raising (SLR) and femoral nerve 
stretch test (FNST) were negative.  An X-ray showed 
degenerative scoliosis,  but an MRI did not display 
narrowing of the lumbar spinal canal (Fig.  1A).  Blood 
tests revealed a white blood cell (WBC) count was 
20,800/µl and eosinophil percentage was 48.7 .  
Chest imaging did not show enlarged lymph nodes but 
displayed peribronchial thickness and minor pulmonary 
inﬁltrates.  A nerve conduction study (NCS) showed an 
axonal neuropathy pattern.  A biopsy of her left sural 
nerve was compatible with small vessel vasculitis and 
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Table 1　 American College of Rheumatology diagnosis criteria for 
eosiophilic granulomatosis with polyangiitis [8]
Asthma (wheezing,  expiratory rhonchi)
Eosinophilia of more than 10% in peripheral blood
Paranasal sinusitis
Pulmonary inﬁltrates (may be transient)
Histological proof of vasculitis with extravascular eosinophilis
Mononeuritis multiplex or polyneuropathy
The presence of four or more criteria yields a sensitivity of 85% and 
a speciﬁcity of 99.7%.
Table 2　 The characteristics and recovery process of our case series
patient 1 patient 2 patient 3 patient 4 patient 5
Age
sex
58
female
59
female
49
female
53
female
84
male
Past
history asthma
eosinophilic
pneumonia asthma asthma asthma
Duration 49 days 10 days 2 days 1 day 1 day
ﬁrst follow ﬁrst follow ﬁrst follow ﬁrst follow ﬁrst follow
Quad 5/5 5/5 5/5 5/5 5/4 5/5 5/5 5/5 5/2 5/4
TA 2/2 5/5 1/5 4/5 5/4 5/5 1/5 4/5 5/5 5/5
EHL 2/2 5/5 1/5 3/5 5/4 5/5 1/5 4/5 5/5 5/5
FHL 2/2 5/5 3/5 3/5 5/4 5/5 2/5 4/5 5/5 5/5
GS 2/2 5/5 4/5 4/5 5/4 5/5 2/5 4/5 5/5 5/5
Duration means the number of days from ﬁrst visit to the start of treatment.
The ﬁgure showed the strength of the right muscle/left muscle on a scale of 0-5 based on the Medical Research Council scale.
Quad,  quadriceps muscle; TA,  tibialis anterior muscle; EHL,  extensor hallucis longus muscle; FHL,  ﬂexsor hallucis longus muscle;  
GS,  gastrocsoleus muscle.
axonal damage.  She was treated with prednisolone and 
later with intravenous cyclophosphamide.  Her muscle 
weakness improved,  but minor dysesthesia remained.
　 Case 2. A 59-year-old female patient presented 
a severe pitting edema and drop-foot and severe dyses-
thesia in her right leg over four weeks.  Her past 
medical history included eosinophilic pneumonia within 
the previous three years.  A physical examination 
revealed severe muscle weakness of her tibialis ante-
rior and extensor hallucis longus.  She had minor 
chronic low back pain,  but SLR and FNST were 
negative.  An MRI did not reveal LDH (Fig.  1B).  
Blood tests showed marked eosinophilia (WBC 
29,600/µl and eosinophil percentage 48.5 ),  and NCS 
showed a mononeuropathy multiplex pattern.  A sural 
nerve biopsy was performed,  and it showed eosino-
philic inﬁltration and ﬁbrosis of her sural nerve.  
Successive treatment with high-dose oral prednisolone 
led to a gradual response.  Moderate improvement of 
her anterior tibial muscle was observed,  but the dys-
esthesia remained.
　 Case 3. A 49-year-old female suﬀered from 
dysesthesia in her left foot for one week,  and the 
dysesthesia spread to her lateral leg.  She visited an 
orthopedic clinic,  and LDH was suspected after a 
physical examination.  After edema emerged in her left 
leg,  she was admitted to our hospital.  She did not 
have low back pain.  SLR and FNST were negative.  
An MRI was not performed because her muscle weak-
ness was moderate,  so no emergency MRI was needed 
before consulting the Department of Rheumatology.  
Her past medical history included asthma for 13 years.  
Physical examinations showed muscle weakness,  hypo-
reﬂexia,  hypoesthesia and pitting edema in the left 
lower leg.  Blood tests revealed eosinophilia (WBC 
25,500/µl and eosinophil percentage 70.5 ) and a lung 
CT and chest X ray showed enlarged lymph nodules 
and pulmonary inﬁltration.  NCS revealed a slightly 
decreased amplitude of the peroneal nerves.  Treatment 
with prednisolone caused rapid improvement of all 
symptoms.
　 Case 4. A 53-year-old female patient was 
admitted due to suspicion of LDH with right L5 or S1 
root radiculopathy.  She had complained of severe 
dysesthesia in the lateral side of her right thigh for 2 
weeks and had dropped foot and minor edema.  
However,  an MRI did not show compression of the 
nerve roots (Fig.  1C).  Her past medical history was 
signiﬁcant in that she was diagnosed with asthma at the 
age of 30.  She sometimes used oral prednisolone at a 
maximum dose of 20mg.  Physical examinations were 
compatible with both radiculopathy and peripheral 
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Fig. 1　 A,  Lumbar spine MRI T2/WI of patient 1.  She had a severe loss of muscle strength in the tibialis anterior (TA),  extensor hallu-
cis longus (EHL),  ﬂexor hallucis longus (FHL),  and gastrocsoleus (GS).  Patient 1 was introduced as an LSS patient; in the sagittal image,  
the alignment showed normal lordosis with a narrow disc height,  and there was no redundancy.  There was no nerve root compression in 
the axial images in L4/5 and L5/S; B,  Lumbar spine MRI T2/WI of patient 2.  She was introduced as an LDH patient with drop-foot.  In 
the sagittal image,  the alignment showed normal lordosis,  and we did not observe narrowing of the spinal canal.  There was no nerve root 
compression on the axial images in L4/5 and L5/S; C,  Lumbar spine MRI T2/WI of patient 4.  She was not able to move her right TA or 
EHL,  and she lost muscle strength in her right FHL and GS.  Patient 4 was introduced as an LDH patient with suspected right L5 or S1 
compression.  Minor disk density changes were observed in L4/5 and L5/S in the sagittal image.  There was no nerve root compression in 
the axial images in L4/5 and L5/S.
neuropathy,  but SLR and FNST were negative.  She 
did not have low back pain.  Blood tests revealed sig-
niﬁcant eosinophilia (WBC 16,000/µl and eosinophil 
percentage 74.5 ).  Her chest X ray showed pulmo-
nary inﬁltration.  NCS showed axonal damage patterns 
of her right peroneal,  tibial,  and sural nerves (Fig.  
2).  A rapid and signiﬁcant improvement was observed 
after high-dose prednisolone and intravenous immuno-
globulin treatment.  Sixteen months later,  the patient 
continued to suﬀer from minor dysesthesia,  but her 
right leg weakness had improved.
　 Case 5. An 84-year-old male patient claimed 
that he could not maintain a standing position and had 
severe dysesthesia in his left leg over the previous one 
week.  He was introduced to our department as an 
LDH patient.  His past medical history included 
asthma in the previous year and sick sinus syndrome 
with pacemaker insertion 6 years before.  A physical 
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NR indicates not recorded.
MCV indicates motor nerve conductive velocity and SCV indicates sensory nerve conduction study.
Fig. 2　 The nerve conduction velocity of patient 4 is shown in the right peroneal nerve (A1),  left peroneal nerve (B1),  right tibial nerve 
(A2),  left tibial nerve (B2),  right sural nerve (A3),  and left sural nerve (B3).  We also show the motor nerve conduction velocity or 
sensory nerve conduction velocity of each nerve (C1,  C2,  and C3).  Her right tibial nerve showed a normal motor nerve conduction 
velocity and low amplitude,  which corresponded to multiple axonal damage patterns.  Moreover,  her right peroneal and sural nerve conduc-
tion velocity could not be recorded.  NR means non-recordable.
examination revealed severe weakness of his left 
quadriceps.  But his FNST and SLR were negative,  
and he had minor chronic low back pain.  Blood tests 
showed marked eosinophilia (WBC 25,700/µl and 
eosinophil percentage 63.5 ),  and NCS showed a 
multiplexus mononeuropathy pattern including his left 
femoral nerve.  His CT scan and chest X ray showed 
pulmonary inﬁltration.  High-dose oral prednisolone led 
to a gradual response.  One year after the treatment,  
he was able to stand and walk by himself despite minor 
dysesthesia around his left knee.  Pregabaline relieved 
his dysesthesia.
Discussion
　 In 1951,  Churg and Strauss [9] ﬁrst described a 
syndrome characterized by asthma and symptoms of 
cardiac failure,  renal damage and peripheral neuropa-
thy resulting from vascular embarrassment in various 
systems of organs.  This disease was known as Churg-
Strauss syndrome for many years,  and this entity was 
renamed and recognized as EGPA at the 2012 Revised 
International Chapel Hill Consensus Conference 
Nomenclature of Vasculitides [10,  11].  EGPA has 3 
stages,  each of which has distinctive clinical symp-
toms [2].  Stage I can last for several years.  Atopic 
asthma and rhinitis are the predominant features of 
this stage,  and they are usually diﬃcult to control.  
Stage II is an eosinophilic stage.  Eosinophil inﬁltra-
tion is seen in various organs,  including the lungs and 
the gastrointestinal tract.  In stage III,  systemic vas-
culitis is observed with general symptoms including 
skin lesions,  peripheral neuropathy,  fever,  weight 
loss,  kidney disorder,  or mononeuropathy multiplex.  
It takes nine years on average to advance from the ﬁrst 
stage to the third stage [4].  Therefore,  in most 
patients,  the upper airway allergy is evident until the 
development of vasculitis,  which causes radiating pain 
or diﬀuse deep pain in the aﬀected legs [12,  13].  All 
our patients characteristically had past histories of 
asthma or eosinophilic pneumonia.  And 4 out of our 5 
patients had peripheral edema.  Local edema on the 
skin of the involved region was observed in EGPA 
[22],  but it is not speciﬁc to radiculopathy.  A past 
history of upper airway allergies and local edema is 
characteristic when mononeuropathy multiplex in 
association with EGPA is taken into consideration,  so 
blood tests,  NCS,  and biopsies should be considered 
as options.
　 Diﬀerentiating mononeuropathy multiplex due to 
GPA from other diseases association with peripheral 
neuropathy is important.  The diﬀerential diagnosis for 
mixed motor and sensory multiple mononeuropathy 
includes diabetic neuropathy,  vasculitides,  sarcoid-
osis,  infectious processes (e.g.,  leprosy,  Lyme disease,  
syphilis,  and cytomegalovirus infection),  amyloidosis,  
and neoplastic inﬁltration (most commonly lymphoma-
tous) [14].  All such diseases were ruled out by blood 
test or image study,  including whole body CT scans,  
in our case series after admission.
　 All patients in our series had subacute paralysis of 
the lower extremities and severe dysesthesia.  
Mononeuropathy multiplex is observed in 50-78  of 
EGPA patients [1,  4,  5].  Hattori N et al.  reported 
that the frequency of individual nerve involvement,  as 
judged by sensory impairment,  was highest in the 
common peroneal nerves,  followed by the tibial,  sural,  
ulnar,  and median nerves [4].  In our series,  peroneal 
nerve palsy could be ruled out because 4 of our 
patients experienced muscle weakness of both the 
anterior tibialis and gastrocsoleus,  which does not 
correspond to peroneal nerve palsy.  Patients with 
EGPA are reported to have radiating pain or diﬀuse 
deep pain in the aﬀected legs [12,  13].  These symp-
toms are similar to those of radiculopathy and periph-
eral neuropathy [6].  However,  the neurological 
symptoms of our case series had some diﬀerent fea-
tures that diﬀered from those of acute monoradicu-
lopathy caused by LDH [12],  which was reported to 
have 58-88  prevalence of a positive SLR result 
[15].  Although the diagnostic accuracy is limited by 
its low speciﬁcity,  the lack of a tension sign or minor 
low back pain might be helpful to rule out radiculopa-
thy in spine diseases because of their high sensitivity 
[15].
　 We ordered emergency MRIs for 3 patients in 
order to rule out LDH or LSS,  and the results were 
negative.  It has been reported that MRI is painless,  
that it does not subject the patient to radiation expo-
sure,  and that it has imaging modalities for diagnosing 
LDH [16].  If these results were positive,  the clinical 
course might have been complicated because emer-
gency operations would then have been considered.  
One report showed that patients with bilateral drop-
foot had both LDH and EGPA [7].  In that case 
report,  the female patient was diagnosed as LDH 
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initially,  and surgical resection of the disc was per-
formed.  However,  her toes and calcaneal areas gradu-
ally became necrotic.  Afterward,  she was diagnosed 
with EGPA,  and both legs required amputation.  In 
order to improve the prognosis of EGPA neuropathy,  
early high-dose steroid treatment is essential [4,  5].  
A separate case report of an EGPA patient is also of 
interest here.  Kukita and associates reported a patient 
who was diagnosed with both EGPA and spinal hema-
toma by MRI examination.  This patient suﬀered from 
urinary incontinence and bilateral leg paralysis [17].  
Considering the diﬀerential diagnosis and complica-
tions,  an MRI may be needed for patients with paraly-
sis of the lower extremities.
　 We performed NCS on all patients to diﬀerentiate 
radiculopathy from mononeuropathy multiplex [18].  
NCS is less invasive than a nerve biopsy.  We per-
formed sural nerve biopsies only in patients 1 and 2 
(Fig.  3),  for whom 49 days and 10 days were needed,  
respectively,  to make a diagnosis of EGPA.  NCS of 
EGPA patients showed axonal degeneration patterns 
[5],  in which the compound motor action potential and 
sensory nerve action potential of damaged nerves were 
decreased or not evoked,  while no delay of conduction 
velocity was seen.  On the other hand,  sensory NCSs 
are normal in radiculopathy,  even if the physical 
examination reveals signiﬁcant sensory loss.  Compound 
motor action potentials are normal if the peripheral 
nerve is damaged.  When multiple root levels are 
involved,  there may be some diminished amplitude in 
such radiculopathy cases [18,  19].  Both MRI and 
NCS are feasible tests for detecting the cause of 
paralysis and dysesthesia of the lower extremities 
when the laboratory data are abnormal.
　 Because of the rarity of EGPA,  a delay of the 
diagnosis might occur in orthopedic departments even 
in university hospitals,  although EGPA may not be 
rare in neuropathic units [20].  Therefore,  we adopted 
a diagnostic algorithm (Fig.  4) after our experience 
with patient 1 in our department.  Between patients 1 
and 5,  we were able to shorten the number of days 
required to make a diagnosis from 49 days to one day.  
The laboratory data of EGPA peripheral neuropathy 
tend to be impressive compared with those of radicu-
lopathy caused by LDH.  All our patientsʼ WBC and 
eosinophil counts were elevated,  and their C-reactive 
protein level was also increased.  These results cor-
respond with those of other reports [4,  5],  and we 
used WBC to screen whether the patientsʼ clinical 
information corresponded to EGPA.  However,  anti-
neutrophilic cytoplasmic antibodies (ANCA),  which 
are characteristic of EGPA,  were negative in all of 
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Fig. 3　 A,  Biopsy section of left sural nerve of patient 1 (hematoxylin and eosin stain).  The sural nerve was totally replaced with ﬁbro-
sis,  and there was no axonal tissue.  Fibroblast cells around the perineuria were observed,  but Schwann cells were not observed.  This 
image was compatible with small vessel vasculitis and axonal damage; B,  Biopsy section of right sural nerve of patient 2 (hematoxylin 
and eosin stain).  Eosinophils (arrow) inﬁltrated into her sural nerve which was totally replaced by ﬁbrosis.  Neuronal vacuolation was 
observed in nerve fasciles.
our patients.  The European case series claimed that 
31  were positive for ANCA [21].  The Korean case 
series showed that neurological involvement was more 
frequent in ANCA-negative patients than in ANCA-
positive patients,  although the diﬀerence was not 
statistically signiﬁcant [22].  These results corre-
sponded to our results.  ANCA-negative patients were 
reported to respond well to their treatment [22].  
Considering its low sensitivity,  neurological features,  
and response to treatment of our patients,  ANCA has 
a weak ability to diagnose EGPA.  Eosinophil counts 
are more cost-eﬀective and more useful for diﬀerenti-
ating the causes of peripheral neurological symptoms 
than ANCA.
　 With respect to the prognosis of EGPA with 
regard to neurological deﬁciency,  there have been no 
detailed reports concerning how EGPA patientsʼ neu-
rological symptoms have improved,  to the best of our 
knowledge.  After we diagnosed these patients as 
having EGPA,  they were referred to the Department 
of Rheumatology of our hospital.  High-dose steroid 
treatment was started from one to 49 days after they 
were introduced to our department,  and all our patientsʼ 
symptoms recovered to a functional level,  including 
the dropped foot (Table 2).  As for peripheral dyses-
theisa,  the area was narrowed and the symptoms were 
relieved to some extent,  but the annoying dysesthesia 
remained.  Pregabaline relieved these symptoms.  In 
order to decrease axonal damage,  early diagnosis and 
steroid treatment are essential [4,  5].
　 In conclusion,  orthopedic doctors and spine neuro-
surgeons should be familiar with the characteristic 
EGPA clinical history in order to make early diagno-
ses,  because EGPA stage III is sometimes misdiag-
nosed as LDH or LSS.  When we encounter patients 
who complain of dysesthesia of their lower extremities 
and who have medical histories of asthma or eosino-
philic pneumonia,  laboratory data and MRI are suit-
able for making an early diagnosis.  Subsequently,  
NCS and biopsies are important for the accurate 
diagnosis of EGPA.
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